Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future. Cancers (Basel) 2022 Jun 03;14(11)

Date

06/11/2022

Pubmed ID

35681756

Pubmed Central ID

PMC9179345

DOI

10.3390/cancers14112776

Scopus ID

2-s2.0-85131173782 (requires institutional sign-in at Scopus site)   2 Citations

Abstract

Cervical cancer is preventable through vaccination, early detection, and the treatment of pre-cancerous lesions. However, global inequalities mean that the disease remains a leading cause of cancer death around the world, with over 80% of new cases and 90% of deaths occurring in low- and middle-income countries (LMICs). In El Salvador, joint efforts between the Ministry of Health (MoH) and the non-profit organization Basic Health International (BHI) have been in place since 2008, with the goal of reducing the country's disease burden. While the World Health Organization's (WHO) call to action to eliminate cervical cancer provided worldwide momentum to implement new public health initiatives, the COVID-19 pandemic disrupted ongoing programs and jeopardized plans for the future. The purpose of this manuscript is to describe the progress that El Salvador has achieved in improving cervical cancer prevention, the impact of the pandemic on current strategies, and potential solutions that can help the country meet the WHO's strategic targets by 2030 to accelerate the elimination of cervical cancer.

Author List

Alfaro K, Soler M, Maza M, Flores M, López L, Rauda JC, Chacón A, Erazo P, Villatoro N, Mumenthaler E, Masch R, Conzuelo G, Felix JC, Cremer M

Author

Juan Felix MD Vice Chair, Director, Professor in the Pathology department at Medical College of Wisconsin